Parkinson's disease
274 results
101 - 200
Lisuride for levodopa‐induced complications in Parkinson's disease- Dopamine agonist therapy in early Parkinson's disease
Cabergoline for levodopa-induced complications in Parkinson's disease - Treadmill training for patients with Parkinson's disease
- Therapies for depression in Parkinson's disease: Cochrane systematic review
- Helicobacter pylori eradication for Parkinson's disease: Cochrane systematic review
Coenzyme Q10 ineffective in Parkinson's disease- Speech and language therapy for dysarthria in Parkinson's disease
- Monoamine oxidase B inhibitors for early Parkinson's disease
- Virtual reality for rehabilitation in Parkinson's disease
- Non‐pharmacological therapies for dysphagia in Parkinson's disease
- Occupational therapy for patients with Parkinson's disease
- Cholinesterase inhibitors for Parkinson's disease dementia: Cochrane systematic review
- Beta‐blocker therapy for tremor in Parkinson's disease
- Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease
- Cabergoline for levodopa‐induced complications in Parkinson's disease
- Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease
- Bromocriptine/levodopa combined vs. levodopa alone for early Parkinson's disease
- Parkinson's disease dementia and dementia with Lewy bodies
- Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease
- Lisuride versus bromocriptine for levodopa‐induced complications in Parkinson's disease
- Ropinirole versus bromocriptine for levodopa‐induced complications in Parkinson's disease
- Speech and language therapy interventions for speech problems in Parkinson's disease
- Physiotherapy for Parkinson's disease: a comparison of techniques
- Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease
- GLP‐1 receptor agonists for Parkinson's disease
- Catechol‐O‐methyltransferase inhibitors for levodopa‐induced complications in Parkinson's disease
- Pharmacological and non‐pharmacological treatments for impulsive‐compulsive behaviors in Parkinson's disease
- Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease
- Parkinson's disease
- Pramipexole for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
- Catechol‐O‐methyltransferase inhibitors versus active comparators for levodopa‐induced complications in Parkinson's disease
- Cabergoline versus bromocriptine for levodopa‐induced complications in Parkinson's disease
- Bromocriptine versus levodopa in early Parkinson's disease
- Physiotherapy versus placebo or no intervention in Parkinson's disease
- Ropinirole for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
- Interventions for orthostatic hypotension in Parkinson's disease: a systematic review and network meta‐analysis
- Comparison of speech and language therapy techniques for speech problems in Parkinson's disease
- Interventions for fatigue in Parkinson's disease
- Pergolide for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
- Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease
- Interventions for preventing falls in Parkinson's disease
- Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
- Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
- Coenzyme Q10 for Parkinson's disease: Cochrane systematic review
- Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies: Cochrane systematic review
- Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials: Cochrane systematic review
- Bromocriptine for levodopa‐induced motor complications in Parkinson's disease
- Nortriptyline better than paroxetine in patients with Parkinson's and depression
- Sustained-release ropinirole improves advanced Parkinson's (EASE-PD)
- Anticholinergics for symptomatic management of Parkinson´s disease
- Tremor
- Obstipation in the adult
- Essential tremor
- Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s disease
- Glycopyrrolate dries excessive salivation
- Tai chi improves balance and reduces falls in Parkinson disease
- Depression, drugs and somatic diseases
- Deep-brain stimulation effective for severe PD
- Clinical assessment of memory impairment
- Whole-body vibration training for patients with neurodegenerative disease: Cochrane systematic review
- Neuropsychological disorders
- Dopamine agents for hepatic encephalopathy